Literature DB >> 29599884

Prevalence of chronic viral hepatitis infections in Karaj, Iran.

Kourosh Kabir1, Hassan Hoseini2,3, Mohammad Miri2,3, Fatemeh Amrollahi2,3, Elham Bahraini4, Parviz Afrogh5, Enayatollah Kalantar6.   

Abstract

INTRODUCTION: Viral hepatitis is challenging for health and blood safety. Studies carried out on blood donors can help find the frequency and trending of hepatitis B and C infections in a community and also safety of donation. The study aim is to determine the prevalence of HBV and HCV in Karaj blood donors over a four year period between 2010 to 2013.
METHODS: This study reports the results of a cross sectional seroepidemiological study of hepatitis B and C in blood donors. Data on hepatitis infection and demographic characteristics of donors were gathered from blood donor registries. Frequency of hepatitis infections were described with 95% confidence interval. Chi square and logistic regression were used for analysis.
RESULTS: The frequency of HBV and HCV infection in Karaj blood donors was 0.40% and 0.18% respectively. In first time donors, HBV and HCV positivity risk was respectively 3.59 and 4.8 fold in people with primary education (OR=3.59; 95% CI between 2.68-4.80) comparing to academic level. Frequency of hepatitis B has decreased significantly (P<0.001) during study period but frequency of Hepatitis C has not changed significantly.
CONCLUSION: The frequencies of HBV and HCV infection in Karaj blood donor population is low. There are equal infection rates within both genders. This must be considered in controlling transmission of infection in this area.

Entities:  

Keywords:  Hepatitis B; Hepatitis C; Iran; blood safety; prevalence

Mesh:

Year:  2017        PMID: 29599884      PMCID: PMC5871252          DOI: 10.11604/pamj.2017.28.186.10269

Source DB:  PubMed          Journal:  Pan Afr Med J


Introduction

Infections due to hepatitis is are a major public health concern all over the world [1, 2]. Individuals with chronic infections have a higher risk of developing liver cirrhosis and hepatocellular carcinoma. This has an important role in disease burden [3-5] and there is a significant financial cost for managing the problem [6]. Blood donation has an important role in the transmission of viral hepatitis particularly hepatitis B and C and is considered a significant challenge to blood safety [7]. The world health organization estimates that over 2 billion people have been exposed to the hepatitis B virus. Approximately 350 million people are chronically infected with HBV [8] and 780 000 people die every year due to complications of hepatitis B [3]. Infected people or asymptomatic carriers are the only reservoir of hepatitis B and C infection. Prevalence of HBsAg carriers in the world has been reported from 0.1% - 20% with high percentage in tropical countries [9-13]. Theoretically the elimination of hepatitis B and c is possible. There are new and accurate strategies for screening of donated blood [7, 14] preventing transfer to others. There are safe vaccines for hepatitis B and effective treatments for chronic infections. The underlying problem lies with the differing approach and strategies by countries based on their resources and access to them, hence the problem continues. There are different studies on the frequency of HBV and HCV in blood donors all over the world which show different prevalence's [9-13, 15]. These studies have shown the frequency and trend of hepatitis B and C infections in the different societies and also a way to show the safety of donation. The Frequency of infected people with hepatitis B and C differs based on region, study type and when the study was carried out [13, 15-18]. Karaj is the capital city of the Alborz Province which is located west of Tehran and has more than 2 million inhabitants in the 2011 census being the fourth most populous city of Iran. There is little information on hepatitis infection in Karaj. Each year about 50,000 residents donate blood giving the opportunity to study the blood borne diseases in the region. The study aims to determine the prevalence of HBV and HCV in Karaj blood donors over a four year period from 2010 to 2013.

Methods

This study reports the results of a cross sectional seroepidemiological study of hepatitis B and C in blood donors of Karaj within a 4 year period from March 2010 - 2013. The blood transfusion organization registries were used for data collection. During the study period 202814 people donated in Karaj. 67828 people were first time donors whilst 134986 people were frequent donors. Multiple donation information was removed from the study by using frequent donors last donation for the analysis. Based on the screening protocol for blood donation in Iran, individuals who were at least 16 years old and in a healthy state were eligible for blood donation. Blood donors were also screened for high risk behaviors by a questionnaire and people with high risk behaviors such as drug use and having multiple partners were not eligible for blood donation. The selected study group went through a blood donation process and a sample of their blood was sent for screening to identify blood infections like hepatitis B and C. All the samples were tested by standard operating procedure (SOP) of Iranian blood transfusion organization. Third and fourth generation ELISA kits respectively were used for screening of HBV and HCV and Confirmatory tests were done for reactive samples of donations. Data on blood donors transferred to SPSS V.19 software. Frequency of hepatitis B and C were described with numbers and percentages within 95% confidence interval. Chi square was used to compare categorical variables. Multivariate logistic regression (using backward Stepwise-Wald method) was used to evaluate demographic variables with Hepatitis B and C in first time donors. Results of logistic regression are presented as OR and 95% CI. Formal written consent was given by blood donors as a part of donation protocol. This study had been approved by the ethics committee of Alborz University of Medical Sciences.

Results

During the study period (March 2010 to 2013) a total of 202814 donations were carried out by 109817 donors. All donations were screened; among which 193 people (0.18%) were positive for HCV and 444 people (0.40%) for HBV. Most of the study group were male (93.7%); moreover 78.6% were married and 27.2% of them had university degrees. Some of the study samples had repeated donations (38.2%) while 61.8% were first time donors (Table 1). Table 1 also shows the frequency of HBsAg positive in relation to gender, age groups, educational level, marital status and history of blood donation. There was no significant difference between male and female HBsAg positive rates but were higher in older age groups (P<0.001). Donors with lower educational levels had higher frequencies of Hepatitis B infection (P<0.001). Married people (P<0.001) and first time donors (P<0.001) also showed higher Hepatitis B infection rates.
Table 1

Frequency of Hepatitis B and C infection in Karaj blood donors and in relation to some of demographic factors

VariableDonors PopulationHepatitis B PositiveP ValueHepatitis C PositiveP Value
Number (%)Number (%)Number (%)
Gender
Male10289593.70%417(0.40%)0.846186(0.180%)0.126
Female69246.30%27(0.39%)7(0.10%)
Age(Years)
15-241306011.9%46(0.35%)<0.001*8(0.06%)0.011*
25-344315039.3%135(0.31%)79(0.18%)
35-443073628%129(0.42%)66(0.21%)
45-541770616.1%100(0.56%)33(0.19%)
≥5551664.7%34(0.66%)7(0.13%)
Education
≤Primary1173710.7%120(1/02%)<0.001*38(0.32%)<0.001*
High school2214220.2%126(0.57%)64(0.28%)
Diploma4599441.9%118(0.26%)71(0.15%)
University Degree2989227.2%79(0.26%)21(0.7%)
Marital Status
Married8609678.6%390(0.45%)<0.001*154(0.18%)0.680
Single2347521.4%54(0.23%)39(0.17%)
Blood Donor
First time6782861.8%431(0.63%)<0.001*185(0.27%)<0.001*
Frequent4199138.2%13(0.03%)8(0.02%)
Total109819100%444(0.40%)---------193(0.18%)------

p value < 0.05 considered as significant

Note: In some parts of table, sum of numbers are not compatible with total numbers because of missing data.

Frequency of Hepatitis B and C infection in Karaj blood donors and in relation to some of demographic factors p value < 0.05 considered as significant Note: In some parts of table, sum of numbers are not compatible with total numbers because of missing data. Table 2 shows the relationship between HBsAg with demographic variables in first time donors. Age, sex, education and marital status was entered into the model. After adjustment, education and marital status were related to being HBs Ag positive. The risk of being HBs positive in people with primary education and high school education was 3.59 (OR=3.59; 95% CI: 2.68-4.80) and 2.05 (OR=2.05; 95% CI: 1.55-2.73) times greater respectively than people with a university degree Single people were at lower risk to have Hepatitis B infection (OR=0.69; 95% CI: 0.51-0.93). Table 3 shows the relationship between Hepatitis C infections (HCV) with demographic variables in first time donors. Age, sex, education and marital state was entered into the model. After adjustment; education and gender were associated with Hepatitis C infection. Comparing people with university degrees the risk of being HCV positive was 4.8 times greater in people with primary education (OR=4.81; 95% CI: 2.82-8.21) and 4.1 times greater in people with high school education level (OR=4.07; 95% CI: 2.48-6.68) and 2.21 times in people with diploma (OR=2.21; 95% CI: 1.36-3.60). Male donors had higher risk of Hepatitis C infections Trend of hepatitis infection in first time blood donors of Karaj are shown in Figure 1. Frequency of hepatitis B infection has decreased significantly (P<0.001) but frequency of Hepatitis C infection has remained unchanged over the years.
Table 2

Adjusted Odds Ratio for Risk factors of Hepatitis B infection in blood donors

BS.E.WalddfSig.Exp(B)95% C.I. for EXP(B)
LowerUpper
Education(Degree) 124.12230.000
≤Primary 1.2790.14874.56110.0003.5942.6884.805
High school 0.7200.14524.71410.0002.0551.5472.730
Diploma -0.0380.1460.06710.7960.9630.7241.281
(Marriage Vs single) -0.3700.1506.11810.0130.6910.5150.926
Constant -5.4700.214655.07810.0000.004

*: p value < 0.05 considered as significant

Table 3

Adjusted Odds Ratio for Risk factors of Hepatitis C infection in blood donors

BS.E.WalddfSig.Exp(B)95% C.I. for EXP(B)
LowerUpper
Education(Degree) 45.85030.000
≤Primary 1.5710.27333.20510.0004.8112.8198.208
High school 1.4050.25231.03510.0004.0742.4856.678
Diploma 0.7940.24910.20910.0012.2121.3593.601
Sex 0.6900.3873.18910.0741.9940.9354.254
Constant -8.6140.794117.71610.0000.000

*: p value < 0.05 considered as significant

Figure 1

Trend of hepatitis B and C infection in Karaj first time blood donors from 2010 to 2013

Adjusted Odds Ratio for Risk factors of Hepatitis B infection in blood donors *: p value < 0.05 considered as significant Adjusted Odds Ratio for Risk factors of Hepatitis C infection in blood donors *: p value < 0.05 considered as significant Trend of hepatitis B and C infection in Karaj first time blood donors from 2010 to 2013

Discussion

Out of 202814 donation during 2010-2013 (from 109817 blood donors), 444 people (0.40%) and 193 people (0.18%) were HBV and HCV positive respectively. The present study shows a low level of endemicity of hepatitis infection in Karaj blood donors´ population. The Frequency of hepatitis B and C infections over the years [2,10, 19] differs within the geographical location within the countries and varies worldwide [17, 20-23]. The Prevalence of hepatitis B and C in blood donors is a reflection of the infections in different communities and they show the same variations [8]. The frequency of hepatitis B and C in Karaj blood donors is relatively low, Comparing to the other regions of Iran, [17, 21, 24] and similarly is lower than some of other Middle Eastern countries such as Jordan which is 1.53%[14]. Our study is also compatible with low frequencies of viral hepatitis in Iranian blood donors. Kafi-abad et al., have reported a prevalence of 0.4% for HBV infection (from 1998-2007 A.C) [15] and a prevalence of 0.56% and 0.13% for hepatitis B and C (from 2004-2007 A.C) in Iranian blood donors [25]. Another study among blood donors from 2005-2011 has reported 0.39% and 0.11% frequencies for Hepatitis B and C infection respectively [13] and a study on Shiraz blood donors showed similar frequencies [26]. On the other hand, there are some population based studies which have reported higher prevalence of hepatitis B and C in Iran but these results are from studies carried out over a decade ago. A study on HBV infection of the general public in 1997 reported a frequency over 5% [20] and Abdolahi et al. in 2006 reported a 9.7% prevalence in Golestan province [17]. A systematic review by Mohammadi et al., shows a decreasing trend of hepatitis B infections especially after 2006. Due to the heterogenic nature of information used the writer suggests carrying out more accurate studies to be able to estimate the point prevalence [27] of the hepatitis B infection. Looking at the results of these studies, [13, 15, 25, 26] there is a decreasing trend of hepatitis B [19, 28] which is compatible with our study results. National vaccination program for hepatitis B which started since 1993 has been successful in decreasing the hepatitis B infection. Furthermore, programs for controlling mother to child transmission, safer blood transfusions and health education campaigns on hepatitis has played a preventative role. Merat et al., has shown the frequency of 0.5% (by RIBA) for hepatitis C infection [16] and another study reported 2.6% (by ELISA) and 1% (by RIBA) for hepatitis C infection in Golestan province [29]. On the other hand, our study doesn't show such a decreasing pattern of hepatitis C infection during the study period in Karaj. Men and women didn't have different positivity rates but donors who were older, had lower educational levels, were married and first time donors, had a higher frequency of HBs Ag. It was the same for hepatitis C positivity rates, except there was no significant difference based on marital status. Some studies have shown that infection rates are similar in both genders [22] but in other studies men generally have higher rates [16, 17, 30]. In our study women were at higher risk of Hepatitis B infection. This was probably due to having hepatitis B positive partners or having more high risk behaviors than other communities. This must be considered as a real public health concern [31] because of the probability of vertical transmission from mothers to child especially for hepatitis B transmissions. There are also higher rate of infection in older people as shown in other studies [22] which could be explained by being at risk for longer period´s time and infection rates being higher in previous decades. On the other hand, having implemented national hepatitis B vaccination program since 1993 in Iran could be another important factor for lower rates of infection in younger groups [32]. According to CDC estimation about 3.9 million people worldwide are infected with HCV, with highest prevalence among the age group 30-39 years [19] which is compatible to the current study carried out on blood donors in Karaj. Blood donors with lower educational level in our study had higher rates of hepatitis B and C, a finding which is being confirmed by other studies [13, 33]. First time blood donors had higher rates of hepatitis infections compared to frequent donors, which is comparable to other studies [13, 30]. This is a result of screening method used for blood safety checks in their first donation. Safety of blood products is important especially in platelets and factors [7, 14]. The low rates of hepatitis infections in Karaj from first time donors by the use of sensitive screening methods, results in low residual risk of transmission and the preparation of a safe blood product.

Conclusion

It seems that chronic hepatitis B and C infection in Karaj is relatively low and blood products have low residual risk of transfusion of hepatitis infections. There are relatively equal infection rates in men and women must be considered in controlling the transmission of infection in our province. Prevalence of chronic hepatitis in the world is different based on the region, preventative measures and treatment strategies; Prevalence of HBV and HCV in blood donors can show the frequency and trend of hepatitis B and C infections in the different societies allowing to show how safe blood donation is in the transmission of hepatitis; There is little information of hepatitis infection in Karaj which is the fourth most populous city in Iran with 50,000 blood donation. It seems that chronic hepatitis B and C infection in Karaj is relatively low and blood products have low residual risk of transfusion of hepatitis infections. Sex, education and marital status were associated with being HBs Ag or hepatitis C positive. Some demographics could be used to stratify the high risk group for blood donation ; There are Relatively equal infection rates in men and women which may suggest the different transmission modes in Karaj compared to other regions.

Competing interests

The authors declare no competing interests.
  26 in total

Review 1.  Current testing strategies for hepatitis C virus infection in blood donors and the way forward.

Authors:  Neelam Marwaha; Suchet Sachdev
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  [HIV, HCV, HBV and syphilis infections among blood donors in Germany 2006. Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act].

Authors:  Levke Willand; S Ritter; B Reinhard; R Offergeld; O Hamouda
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2008-08       Impact factor: 1.513

Review 3.  Hepatitis C virus infection, antiviral therapy, and risk of hepatocellular carcinoma.

Authors:  Yao-Chun Hsu; Chun-Ying Wu; Jaw-Town Lin
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

4.  The Global Burden of Cancer 2013.

Authors:  Christina Fitzmaurice; Daniel Dicker; Amanda Pain; Hannah Hamavid; Maziar Moradi-Lakeh; Michael F MacIntyre; Christine Allen; Gillian Hansen; Rachel Woodbrook; Charles Wolfe; Randah R Hamadeh; Ami Moore; Andrea Werdecker; Bradford D Gessner; Braden Te Ao; Brian McMahon; Chante Karimkhani; Chuanhua Yu; Graham S Cooke; David C Schwebel; David O Carpenter; David M Pereira; Denis Nash; Dhruv S Kazi; Diego De Leo; Dietrich Plass; Kingsley N Ukwaja; George D Thurston; Kim Yun Jin; Edgar P Simard; Edward Mills; Eun-Kee Park; Ferrán Catalá-López; Gabrielle deVeber; Carolyn Gotay; Gulfaraz Khan; H Dean Hosgood; Itamar S Santos; Janet L Leasher; Jasvinder Singh; James Leigh; Jost B Jonas; Jost Jonas; Juan Sanabria; Justin Beardsley; Kathryn H Jacobsen; Ken Takahashi; Richard C Franklin; Luca Ronfani; Marcella Montico; Luigi Naldi; Marcello Tonelli; Johanna Geleijnse; Max Petzold; Mark G Shrime; Mustafa Younis; Naohiro Yonemoto; Nicholas Breitborde; Paul Yip; Farshad Pourmalek; Paulo A Lotufo; Alireza Esteghamati; Graeme J Hankey; Raghib Ali; Raimundas Lunevicius; Reza Malekzadeh; Robert Dellavalle; Robert Weintraub; Robyn Lucas; Roderick Hay; David Rojas-Rueda; Ronny Westerman; Sadaf G Sepanlou; Sandra Nolte; Scott Patten; Scott Weichenthal; Semaw Ferede Abera; Seyed-Mohammad Fereshtehnejad; Ivy Shiue; Tim Driscoll; Tommi Vasankari; Ubai Alsharif; Vafa Rahimi-Movaghar; Vasiliy V Vlassov; W S Marcenes; Wubegzier Mekonnen; Yohannes Adama Melaku; Yuichiro Yano; Al Artaman; Ismael Campos; Jennifer MacLachlan; Ulrich Mueller; Daniel Kim; Matias Trillini; Babak Eshrati; Hywel C Williams; Kenji Shibuya; Rakhi Dandona; Kinnari Murthy; Benjamin Cowie; Azmeraw T Amare; Carl Abelardo Antonio; Carlos Castañeda-Orjuela; Coen H van Gool; Francesco Violante; In-Hwan Oh; Kedede Deribe; Kjetil Soreide; Luke Knibbs; Maia Kereselidze; Mark Green; Rosario Cardenas; Nobhojit Roy; Taavi Tillmann; Taavi Tillman; Yongmei Li; Hans Krueger; Lorenzo Monasta; Subhojit Dey; Sara Sheikhbahaei; Nima Hafezi-Nejad; G Anil Kumar; Chandrashekhar T Sreeramareddy; Lalit Dandona; Haidong Wang; Stein Emil Vollset; Ali Mokdad; Joshua A Salomon; Rafael Lozano; Theo Vos; Mohammad Forouzanfar; Alan Lopez; Christopher Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2015-07       Impact factor: 31.777

5.  Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.

Authors:  S Amini Kafi-abad; H Rezvan; H Abolghasemi
Journal:  Transfus Med       Date:  2009-08       Impact factor: 2.019

6.  Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011.

Authors:  Fatemeh Mohammadali; Ali Akbar Pourfathollah
Journal:  Arch Iran Med       Date:  2014-09       Impact factor: 1.354

7.  Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.

Authors:  Sedigheh Amini Kafi-abad; Houri Rezvan; Hassan Abolghasemi; Ali Talebian
Journal:  Transfusion       Date:  2009-06-10       Impact factor: 3.157

8.  Seroepidemiology of HBV infection in South-East of iran; a population based study.

Authors:  M Salehi; S M Alavian; S V Tabatabaei; Sh Izadi; E Sanei Moghaddam; S Amini Kafi-Abad; A Gharehbaghian; S Khosravi; H Abolghasemi
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

Review 9.  Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population Studies.

Authors:  Zahra Mohammadi; Abbasali Keshtkar; Sareh Eghtesad; Alireza Jeddian; Ali Akbar Pourfatholah; Mahtab Maghsudlu; Maryam Zadsar; Zahra Mahmoudi; Amaneh Shayanrad; Hossein Poustchi; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2016-01

10.  Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection--sub-Saharan Africa, 2000-2011.

Authors:  Ibironke W Apata; Francisco Averhoff; John Pitman; Adam Bjork; Junping Yu; Noryati Abu Amin; Neelam Dhingra; Amy Kolwaite; Anthony Marfin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-25       Impact factor: 17.586

View more
  1 in total

1.  Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS).

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Mohammadreza Naghipour; Soheil Hassanipour; Sara Yeganeh; Masood Sepehrimanesh; Mohammad Fathalipour
Journal:  BMC Res Notes       Date:  2021-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.